Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Toxicology and Pharmacology of Drugs for Cancer
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Temporal Specification of Basal Forebrain Circuitry
Sulforaphane as an inhibitor of HIV infection
Identification of Novel MicroRNAs Associated with Brain Structure and Function
Alcohol SBIRT Implementation in an HMO: Non-Physician Providers vs. Physicians
Statistics and Genomics - a work program
Recently added grants:
EphA2 mediates opening of the blood brain barrier in cerebral malaria
Promoting and understanding recovery of breathing after chronic spinal cord injury
Androgen receptors and sex differences in the biological clock
Thalamic Contributions to the developing EEG
Intranasal LIF to improve neurological recovery from perinatal hypoxia-ischema
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM42202-13-0-1
Application #
7581693
Study Section
Project Start
2004-04-01
Project End
2011-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Toxicology and Pharmacology of Drugs for Cancer
/ Iit Research Institute
$1,741,870
NIH 2007
N01 CA
Preclinical Toxicology and Pharmacology of Drugs Developed for Cancer, AIDS, and
McCormick, David /
$1,272,233
NIH 2007
N01 CA
Preclinical Toxicology and Pharmacology of Drugs for Cancer
/
Comments
Be the first to comment on this grant